These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 16978447)

  • 1. Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?
    Lashuel HA; Lansbury PT
    Q Rev Biophys; 2006 May; 39(2):167-201. PubMed ID: 16978447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane permeabilization: a common mechanism in protein-misfolding diseases.
    Lashuel HA
    Sci Aging Knowledge Environ; 2005 Sep; 2005(38):pe28. PubMed ID: 16186179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G; Schlüter OM; Südhof TC
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic animal models of neurodegenerative diseases and their application to treatment development.
    Rockenstein E; Crews L; Masliah E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1093-102. PubMed ID: 17869376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular Abeta and C99 aggregates induce mitochondria-dependent cell death in human neuroglioma H4 cells through recruitment of the 20S proteasome subunits.
    Park HJ; Kim SS; Kang S; Rhim H
    Brain Res; 2009 Jun; 1273():1-8. PubMed ID: 19362074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role for oxidative stress in neurodegenerative diseases].
    Shibata N; Kobayashi M
    Brain Nerve; 2008 Feb; 60(2):157-70. PubMed ID: 18306664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apoptosis in neurodegenerative diseases: facts and controversies].
    Jiménez del Rio M; Vélez-Pardo C
    Rev Neurol; 2001 May 1-15; 32(9):851-60. PubMed ID: 11424038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction.
    Tai HC; Schuman EM
    Nat Rev Neurosci; 2008 Nov; 9(11):826-38. PubMed ID: 18931696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid peptides in different assembly states and related effects on isolated and cellular proteasomes.
    Cecarini V; Bonfili L; Amici M; Angeletti M; Keller JN; Eleuteri AM
    Brain Res; 2008 May; 1209():8-18. PubMed ID: 18400214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane pores in the pathogenesis of neurodegenerative disease.
    Kagan BL
    Prog Mol Biol Transl Sci; 2012; 107():295-325. PubMed ID: 22482454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis.
    Glabe CG; Kayed R
    Neurology; 2006 Jan; 66(2 Suppl 1):S74-8. PubMed ID: 16432151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition.
    Askanas V; Engel WK
    Neurology; 2006 Jan; 66(2 Suppl 1):S39-48. PubMed ID: 16432144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress and neurotoxicity.
    Sayre LM; Perry G; Smith MA
    Chem Res Toxicol; 2008 Jan; 21(1):172-88. PubMed ID: 18052107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of polyunsaturated fatty acids for misfolding protein aggregations: implication for neurodegenerative diseases.
    Kim YJ; Takahashi R
    Ann N Y Acad Sci; 2006 Nov; 1086():11-20. PubMed ID: 17185502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.
    Schell H; Hasegawa T; Neumann M; Kahle PJ
    Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.
    Aigelsreiter A; Janig E; Stumptner C; Fuchsbichler A; Zatloukal K; Denk H
    Pathobiology; 2007; 74(3):145-58. PubMed ID: 17643060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein oxidation and degradation during aging: role in skin aging and neurodegeneration.
    Widmer R; Ziaja I; Grune T
    Free Radic Res; 2006 Dec; 40(12):1259-68. PubMed ID: 17090415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases.
    Ferreira ST; Vieira MN; De Felice FG
    IUBMB Life; 2007; 59(4-5):332-45. PubMed ID: 17505973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease.
    Wang X; Su B; Perry G; Smith MA; Zhu X
    Free Radic Biol Med; 2007 Dec; 43(12):1569-73. PubMed ID: 18037122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-target-directed ligands to combat neurodegenerative diseases.
    Cavalli A; Bolognesi ML; Minarini A; Rosini M; Tumiatti V; Recanatini M; Melchiorre C
    J Med Chem; 2008 Feb; 51(3):347-72. PubMed ID: 18181565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.